Osmia bicornis bicornis chromosome 8, iOsmBic2.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Megachilidae; Megachilinae; Osmia.
REFSEQ INFORMATION: The reference sequence is identical to\nOU015511.1.\nAssembly name: iOsmBic2.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/05/17. The original whole-genome shotgun project has the\naccession CAJRAL000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Osmia bicornis bicornis Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
golgin subfamily A member 6-like protein 6
uncharacterized LOC114881657, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC114881657, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65% coverage of the annotated genomic feature by RNAseq alignments
cilia- and flagella-associated protein 251-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: putative nuclease HARBI1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microprocessor complex subunit DGCR8, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
microprocessor complex subunit DGCR8, transcript variant X2
microprocessor complex subunit DGCR8, transcript variant X3
microprocessor complex subunit DGCR8, transcript variant X4
microprocessor complex subunit DGCR8, transcript variant X7
microprocessor complex subunit DGCR8, transcript variant X5
microprocessor complex subunit DGCR8, transcript variant X6
microprocessor complex subunit DGCR8, transcript variant X8
microprocessor complex subunit DGCR8 isoform X1
microprocessor complex subunit DGCR8, transcript variant X9
microprocessor complex subunit DGCR8 isoform X2
RILP-like protein homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
RILP-like protein homolog, transcript variant X3
RILP-like protein homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
RILP-like protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
RILP-like protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
FHIP family protein AAEL005291, transcript variant X2
FHIP family protein AAEL005291, transcript variant X4
FHIP family protein AAEL005291, transcript variant X1
FHIP family protein AAEL005291, transcript variant X3
FHIP family protein AAEL005291 isoform X3
FHIP family protein AAEL005291 isoform X2
FHIP family protein AAEL005291 isoform X1
myb/SANT-like DNA-binding domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 72% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
probable RNA-binding protein CG14230, transcript variant X1
probable RNA-binding protein CG14230, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable RNA-binding protein CG14230 isoform X1
probable RNA-binding protein CG14230 isoform X2
farnesyl pyrophosphate synthase-like, transcript variant X1
farnesyl pyrophosphate synthase-like, transcript variant X2
farnesyl pyrophosphate synthase-like, transcript variant X3
farnesyl pyrophosphate synthase-like isoform X1
farnesyl pyrophosphate synthase-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114881037, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC114881037, transcript variant X3
uncharacterized LOC114881037, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel trpm, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X3
transient receptor potential cation channel trpm, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transient receptor potential cation channel trpm isoform X2
transient receptor potential cation channel trpm isoform X1
transient receptor potential cation channel trpm isoform X4
transient receptor potential cation channel trpm isoform X3
transient receptor potential cation channel trpm isoform X5
transient receptor potential cation channel trpm isoform X6
superoxide dismutase [Cu-Zn], transcript variant X2
superoxide dismutase [Cu-Zn], transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7-like
phosphatidylinositol 4-kinase alpha, transcript variant X1
phosphatidylinositol 4-kinase alpha, transcript variant X3
phosphatidylinositol 4-kinase alpha, transcript variant X2
phosphatidylinositol 4-kinase alpha isoform X3
phosphatidylinositol 4-kinase alpha isoform X2
phosphatidylinositol 4-kinase alpha isoform X1
zinc finger HIT domain-containing protein 2
TNF receptor-associated factor 6-like, transcript variant X1
TNF receptor-associated factor 6-like, transcript variant X2
TNF receptor-associated factor 6-like isoform X1
TNF receptor-associated factor 6-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
uncharacterized LOC123988034, transcript variant X2
uncharacterized LOC123988034, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
piggyBac transposable element-derived protein 4-like, transcript variant X2
piggyBac transposable element-derived protein 4-like, transcript variant X1
piggyBac transposable element-derived protein 4-like isoform X1
piggyBac transposable element-derived protein 4-like isoform X2
uncharacterized LOC123988047, transcript variant X2
uncharacterized LOC123988047, transcript variant X1
conserved oligomeric Golgi complex subunit 8
chymotrypsin-like elastase family member 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
39S ribosomal protein L39, mitochondrial, transcript variant X1
39S ribosomal protein L39, mitochondrial, transcript variant X2
39S ribosomal protein L39, mitochondrial isoform X1
39S ribosomal protein L39, mitochondrial isoform X2
DNA-directed RNA polymerase III subunit RPC10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
yrdC domain-containing protein, mitochondrial
synaptic vesicle glycoprotein 2A-like, transcript variant X2
synaptic vesicle glycoprotein 2A-like, transcript variant X1
synaptic vesicle glycoprotein 2A-like, transcript variant X3
synaptic vesicle glycoprotein 2A-like isoform X2
synaptic vesicle glycoprotein 2A-like isoform X1
synaptic vesicle glycoprotein 2A-like isoform X3
proton-associated sugar transporter A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proton-associated sugar transporter A, transcript variant X2
malate dehydrogenase 3, cytoplasmic-like
phenylalanine--tRNA ligase alpha subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
phenylalanine--tRNA ligase alpha subunit isoform X2
phenylalanine--tRNA ligase alpha subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phenylalanine--tRNA ligase alpha subunit isoform X1
L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
dynein axonemal intermediate chain 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
apolipoprotein D-like, transcript variant X1
apolipoprotein D-like, transcript variant X2
cyclin-dependent kinase 1, transcript variant X1
cyclin-dependent kinase 1, transcript variant X2
arginine/serine-rich coiled-coil protein 2, transcript variant X3
arginine/serine-rich coiled-coil protein 2, transcript variant X1
arginine/serine-rich coiled-coil protein 2, transcript variant X2
arginine/serine-rich coiled-coil protein 2 isoform X1
arginine/serine-rich coiled-coil protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ubiquitin-fold modifier 1, transcript variant X4
ubiquitin-fold modifier 1, transcript variant X3
ubiquitin-fold modifier 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ubiquitin-fold modifier 1, transcript variant X1
uncharacterized protein LOC114880131 isoform X1
signal peptide peptidase-like 3, transcript variant X4
signal peptide peptidase-like 3, transcript variant X1
signal peptide peptidase-like 3, transcript variant X3
signal peptide peptidase-like 3, transcript variant X5
signal peptide peptidase-like 3, transcript variant X2
calcium release-activated calcium channel protein 1-like, transcript variant X2
calcium release-activated calcium channel protein 1-like, transcript variant X1
calcium release-activated calcium channel protein 1-like isoform X2
calcium release-activated calcium channel protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
homeobox protein 4-like, transcript variant X4
homeobox protein 4-like, transcript variant X2
homeobox protein 4-like, transcript variant X3
homeobox protein 4-like, transcript variant X1
probable serine/threonine-protein kinase samkC isoform X1
LIM domain kinase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
LIM domain kinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC114881643, transcript variant X2
uncharacterized LOC114881643, transcript variant X1
uncharacterized protein LOC114881643 isoform X1
uncharacterized protein LOC114881643 isoform X2
uncharacterized LOC123988056, transcript variant X1
uncharacterized LOC123988056, transcript variant X2
uncharacterized protein LOC123988056 isoform X1
uncharacterized protein LOC123988056 isoform X2
uncharacterized LOC114881549, transcript variant X3
uncharacterized LOC114881549, transcript variant X1
uncharacterized LOC114881549, transcript variant X2
uncharacterized protein LOC114881549 isoform X1
uncharacterized protein LOC114881549 isoform X2
uncharacterized LOC123988020, transcript variant X2
uncharacterized LOC123988020, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123988020, transcript variant X1
uncharacterized LOC123988027, transcript variant X7
uncharacterized LOC123988027, transcript variant X1
uncharacterized LOC123988027, transcript variant X6
uncharacterized LOC123988027, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC123988027, transcript variant X4
uncharacterized LOC123988027, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123988027, transcript variant X3
elongation of very long chain fatty acids protein 1-like
uncharacterized LOC114882172, transcript variant X2
uncharacterized LOC114882172, transcript variant X1
uncharacterized protein LOC114882172 isoform X2
uncharacterized protein LOC114882172 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
breast cancer metastasis-suppressor 1-like protein
uncharacterized LOC114881039, transcript variant X3
uncharacterized LOC114881039, transcript variant X2
uncharacterized LOC114881039, transcript variant X1
uncharacterized LOC114881039, transcript variant X4
uncharacterized LOC114881039, transcript variant X5
uncharacterized protein LOC114881039 isoform X2
uncharacterized protein LOC114881039 isoform X1
uncharacterized protein LOC114881039 isoform X3
cytoglobin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytoglobin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
jerky protein homolog-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
jerky protein homolog-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MD-2-related lipid-recognition protein-like
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
echinoderm microtubule-associated protein-like 2, transcript variant X4
echinoderm microtubule-associated protein-like 2, transcript variant X5
echinoderm microtubule-associated protein-like 2 isoform X3
echinoderm microtubule-associated protein-like 2, transcript variant X1
echinoderm microtubule-associated protein-like 2, transcript variant X8
echinoderm microtubule-associated protein-like 2, transcript variant X11
echinoderm microtubule-associated protein-like 2, transcript variant X10
echinoderm microtubule-associated protein-like 2, transcript variant X3
echinoderm microtubule-associated protein-like 2, transcript variant X7
echinoderm microtubule-associated protein-like 2, transcript variant X9
echinoderm microtubule-associated protein-like 2, transcript variant X6
echinoderm microtubule-associated protein-like 2, transcript variant X2
echinoderm microtubule-associated protein-like 2 isoform X1
echinoderm microtubule-associated protein-like 2 isoform X4
echinoderm microtubule-associated protein-like 2 isoform X6
echinoderm microtubule-associated protein-like 2 isoform X9
echinoderm microtubule-associated protein-like 2 isoform X8
echinoderm microtubule-associated protein-like 2 isoform X2
echinoderm microtubule-associated protein-like 2 isoform X5
echinoderm microtubule-associated protein-like 2 isoform X7
G1/S-specific cyclin-D2, transcript variant X1
G1/S-specific cyclin-D2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC114875758, transcript variant X5
uncharacterized LOC114875758, transcript variant X3
uncharacterized LOC114875758, transcript variant X2
uncharacterized LOC114875758, transcript variant X1
uncharacterized LOC114875758, transcript variant X4
uncharacterized protein LOC114875758 isoform X4
uncharacterized protein LOC114875758 isoform X2
uncharacterized protein LOC114875758 isoform X1
uncharacterized protein LOC114875758 isoform X3
transmembrane emp24 domain-containing protein 7-like
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1
spermatogenesis-associated protein 20, transcript variant X9
spermatogenesis-associated protein 20, transcript variant X8
spermatogenesis-associated protein 20 isoform X4
spermatogenesis-associated protein 20, transcript variant X1
spermatogenesis-associated protein 20, transcript variant X2
spermatogenesis-associated protein 20, transcript variant X3
spermatogenesis-associated protein 20, transcript variant X6
spermatogenesis-associated protein 20, transcript variant X10
spermatogenesis-associated protein 20, transcript variant X5
spermatogenesis-associated protein 20, transcript variant X11
spermatogenesis-associated protein 20, transcript variant X4
spermatogenesis-associated protein 20, transcript variant X13
spermatogenesis-associated protein 20 isoform X1
spermatogenesis-associated protein 20 isoform X2
spermatogenesis-associated protein 20, transcript variant X7
spermatogenesis-associated protein 20, transcript variant X12
spermatogenesis-associated protein 20 isoform X3
spermatogenesis-associated protein 20 isoform X5
voltage-dependent T-type calcium channel subunit alpha-1G
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: voltage-dependent T-type calcium channel subunit alpha-1G
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
LOW QUALITY PROTEIN: SUN domain-containing protein 1-like
tetratricopeptide repeat protein 39C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tetratricopeptide repeat protein 39C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tetratricopeptide repeat protein 39C-like isoform X2
tetratricopeptide repeat protein 39C-like isoform X1
soluble calcium-activated nucleotidase 1
uncharacterized LOC114875746, transcript variant X2
uncharacterized LOC114875746, transcript variant X3
uncharacterized LOC114875746, transcript variant X1
zinc finger BED domain-containing protein 5-like
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC114878166, transcript variant X3
uncharacterized LOC114878166, transcript variant X1
uncharacterized protein LOC114878166 isoform X1
uncharacterized LOC114878166, transcript variant X2
uncharacterized protein LOC114878166 isoform X2
plant intracellular Ras-group-related LRR protein 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein O-GlcNAcase, transcript variant X2
protein O-GlcNAcase, transcript variant X3
protein O-GlcNAcase, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X4
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X3
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X4
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X3
octopamine receptor beta-1R-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
octopamine receptor beta-1R-like, transcript variant X2
octopamine receptor beta-1R-like isoform X1
octopamine receptor beta-1R-like isoform X2
uncharacterized LOC114878172, transcript variant X2
uncharacterized LOC114878172, transcript variant X1
uncharacterized LOC114878172, transcript variant X3
octopamine receptor beta-3R-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
octopamine receptor beta-3R-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
octopamine receptor beta-3R-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
octopamine receptor beta-3R-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
octopamine receptor beta-3R-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
octopamine receptor beta-3R-like isoform X2
octopamine receptor beta-3R-like isoform X1
octopamine receptor beta-3R-like, transcript variant X6
octopamine receptor beta-3R-like isoform X3
octopamine receptor beta-2R-like, transcript variant X5
octopamine receptor beta-2R-like, transcript variant X2
octopamine receptor beta-2R-like, transcript variant X4
octopamine receptor beta-2R-like, transcript variant X3
octopamine receptor beta-2R-like, transcript variant X1
octopamine receptor beta-2R-like isoform X1
octopamine receptor beta-2R-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
octopamine receptor beta-2R-like isoform X2
octopamine receptor beta-2R-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
octopamine receptor beta-2R-like isoform X3
facilitated trehalose transporter Tret1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
facilitated trehalose transporter Tret1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
facilitated trehalose transporter Tret1-like isoform X1
facilitated trehalose transporter Tret1-like isoform X2
BTB/POZ domain-containing protein KCTD9, transcript variant X2
BTB/POZ domain-containing protein KCTD9, transcript variant X3
BTB/POZ domain-containing protein KCTD9, transcript variant X5
BTB/POZ domain-containing protein KCTD9, transcript variant X1
BTB/POZ domain-containing protein KCTD9, transcript variant X4
BTB/POZ domain-containing protein KCTD9 isoform X2
BTB/POZ domain-containing protein KCTD9 isoform X1
BTB/POZ domain-containing protein KCTD9 isoform X3
biorientation of chromosomes in cell division protein 1-like 1
mitoferrin-1-like, transcript variant X1
mitoferrin-1-like, transcript variant X2
mitoferrin-1-like, transcript variant X3
uncharacterized LOC114877112, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC114877112, transcript variant X2
ATP-dependent RNA helicase SUV3 homolog, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ATP-dependent RNA helicase SUV3 homolog, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ATP-dependent RNA helicase SUV3 homolog, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ATP-dependent RNA helicase SUV3 homolog, mitochondrial isoform X1
ATP-dependent RNA helicase SUV3 homolog, mitochondrial isoform X2
ATP-dependent RNA helicase SUV3 homolog, mitochondrial isoform X3
CDK5 regulatory subunit-associated protein 3
ubiquitin thioesterase trabid, transcript variant X5
ubiquitin thioesterase trabid, transcript variant X3
ubiquitin thioesterase trabid, transcript variant X2
ubiquitin thioesterase trabid, transcript variant X7
ubiquitin thioesterase trabid, transcript variant X1
ubiquitin thioesterase trabid, transcript variant X4
ubiquitin thioesterase trabid isoform X3
ubiquitin thioesterase trabid, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ubiquitin thioesterase trabid isoform X1
ubiquitin thioesterase trabid isoform X2
NADPH-dependent diflavin oxidoreductase 1-like, transcript variant X2
NADPH-dependent diflavin oxidoreductase 1-like isoform X2
NADPH-dependent diflavin oxidoreductase 1-like, transcript variant X1
equilibrative nucleoside transporter 1-like isoform X1
C-terminal-binding protein, transcript variant X1
C-terminal-binding protein, transcript variant X2
C-terminal-binding protein, transcript variant X5
C-terminal-binding protein, transcript variant X6
C-terminal-binding protein, transcript variant X3
C-terminal-binding protein, transcript variant X4
ATP-binding cassette sub-family D member
osmotic avoidance abnormal protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
cytochrome c oxidase assembly factor 7 homolog, transcript variant X1
cytochrome c oxidase assembly factor 7 homolog, transcript variant X2
cytochrome c oxidase assembly factor 7 homolog isoform X1
cytochrome c oxidase assembly factor 7 homolog isoform X2
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase
gamma-interferon-inducible lysosomal thiol reductase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114877094, transcript variant X4
uncharacterized LOC114877094, transcript variant X5
uncharacterized protein LOC114877094 isoform X5
uncharacterized protein LOC114877094 isoform X4
uncharacterized LOC114877100, transcript variant X2
uncharacterized LOC114877100, transcript variant X1
uncharacterized LOC114877094, transcript variant X1
uncharacterized LOC114877094, transcript variant X2
uncharacterized LOC114877094, transcript variant X3
uncharacterized LOC114877094, transcript variant X6
uncharacterized protein LOC114877094 isoform X1
uncharacterized protein LOC114877094 isoform X2
uncharacterized protein LOC114877094 isoform X3
uncharacterized protein LOC114877094 isoform X6
transcriptional activator protein Pur-beta, transcript variant X4
transcriptional activator protein Pur-beta, transcript variant X5
transcriptional activator protein Pur-beta isoform X3
transcriptional activator protein Pur-beta isoform X4
transcriptional activator protein Pur-beta, transcript variant X8
transcriptional activator protein Pur-beta isoform X7
transcriptional activator protein Pur-beta, transcript variant X1
transcriptional activator protein Pur-beta, transcript variant X2
transcriptional activator protein Pur-beta, transcript variant X3
transcriptional activator protein Pur-beta isoform X1
transcriptional activator protein Pur-beta isoform X2
transcriptional activator protein Pur-beta, transcript variant X6
transcriptional activator protein Pur-beta, transcript variant X7
transcriptional activator protein Pur-beta isoform X5
transcriptional activator protein Pur-beta isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 72% coverage of the annotated genomic feature by RNAseq alignments
nucleolar protein 14 homolog, transcript variant X2
nucleolar protein 14 homolog, transcript variant X1
probable 39S ribosomal protein L45, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X1
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X2
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X3
tyrosine-protein kinase transmembrane receptor Ror isoform X1
tyrosine-protein kinase transmembrane receptor Ror isoform X2
tyrosine-protein kinase transmembrane receptor Ror isoform X3
uncharacterized LOC114880212, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC114880212 isoform X1
uncharacterized LOC114880212, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC114880212, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC114880212, transcript variant X4
uncharacterized protein LOC114880212 isoform X2
uncharacterized LOC114880212, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC114880212 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
transcription elongation factor SPT5, transcript variant X2
transcription elongation factor SPT5, transcript variant X1
transcription elongation factor SPT5 isoform X2
transcription elongation factor SPT5 isoform X1
vacuolar protein sorting-associated protein 13, transcript variant X1
vacuolar protein sorting-associated protein 13, transcript variant X3
vacuolar protein sorting-associated protein 13, transcript variant X4
vacuolar protein sorting-associated protein 13, transcript variant X6
vacuolar protein sorting-associated protein 13, transcript variant X10
vacuolar protein sorting-associated protein 13, transcript variant X8
vacuolar protein sorting-associated protein 13, transcript variant X9
vacuolar protein sorting-associated protein 13, transcript variant X11
vacuolar protein sorting-associated protein 13, transcript variant X12
vacuolar protein sorting-associated protein 13, transcript variant X5
vacuolar protein sorting-associated protein 13, transcript variant X7
vacuolar protein sorting-associated protein 13, transcript variant X13
vacuolar protein sorting-associated protein 13, transcript variant X2
vacuolar protein sorting-associated protein 13 isoform X1
vacuolar protein sorting-associated protein 13 isoform X3
vacuolar protein sorting-associated protein 13 isoform X7
vacuolar protein sorting-associated protein 13 isoform X5
vacuolar protein sorting-associated protein 13 isoform X6
vacuolar protein sorting-associated protein 13 isoform X8
vacuolar protein sorting-associated protein 13 isoform X9
vacuolar protein sorting-associated protein 13 isoform X2
vacuolar protein sorting-associated protein 13 isoform X4
vacuolar protein sorting-associated protein 13 isoform X10
protein lifeguard 3-like, transcript variant X1
protein lifeguard 3-like, transcript variant X3
protein lifeguard 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tetratricopeptide repeat protein 21B-like
threonine--tRNA ligase 1, cytoplasmic, transcript variant X2
threonine--tRNA ligase 1, cytoplasmic, transcript variant X3
threonine--tRNA ligase 1, cytoplasmic isoform X2
threonine--tRNA ligase 1, cytoplasmic isoform X3
threonine--tRNA ligase 1, cytoplasmic, transcript variant X1
threonine--tRNA ligase 1, cytoplasmic isoform X1
zinc finger protein ubi-d4 A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger protein ubi-d4 A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
iodotyrosine deiodinase 1, transcript variant X3
iodotyrosine deiodinase 1, transcript variant X2
iodotyrosine deiodinase 1, transcript variant X4
iodotyrosine deiodinase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
iodotyrosine deiodinase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ribosomal protein S6 kinase alpha-5-like, transcript variant X4
ribosomal protein S6 kinase alpha-5-like isoform X2
ribosomal protein S6 kinase alpha-5-like, transcript variant X2
ribosomal protein S6 kinase alpha-5-like, transcript variant X1
ribosomal protein S6 kinase alpha-5-like, transcript variant X3
ribosomal protein S6 kinase alpha-5-like, transcript variant X5
ribosomal protein S6 kinase alpha-5-like isoform X1
ribosomal protein S6 kinase alpha-5-like isoform X3
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ADP-ribose glycohydrolase ARH3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ADP-ribose glycohydrolase ARH3-like isoform X1
ADP-ribose glycohydrolase ARH3-like, transcript variant X2
ADP-ribose glycohydrolase ARH3-like isoform X2
ras-related and estrogen-regulated growth inhibitor, transcript variant X2
ras-related and estrogen-regulated growth inhibitor, transcript variant X1
ras-related and estrogen-regulated growth inhibitor
coatomer subunit beta, transcript variant X2
coatomer subunit beta, transcript variant X1
coatomer subunit beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 13% coverage of the annotated genomic feature by RNAseq alignments
RING finger protein narya, transcript variant X2
RING finger protein narya, transcript variant X1
S-adenosylmethionine mitochondrial carrier protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
hydroxysteroid dehydrogenase-like protein 2
asparagine synthetase domain-containing protein 1, transcript variant X2
asparagine synthetase domain-containing protein 1, transcript variant X4
asparagine synthetase domain-containing protein 1, transcript variant X5
asparagine synthetase domain-containing protein 1, transcript variant X3
asparagine synthetase domain-containing protein 1, transcript variant X1
asparagine synthetase domain-containing protein 1
Kv channel-interacting protein 1, transcript variant X1
Kv channel-interacting protein 1, transcript variant X4
Kv channel-interacting protein 1, transcript variant X2
Kv channel-interacting protein 1, transcript variant X3
dynein regulatory complex subunit 5-like
mitotic-spindle organizing protein 1-like
serine/threonine-protein kinase 11-interacting protein, transcript variant X1
serine/threonine-protein kinase 11-interacting protein, transcript variant X3
serine/threonine-protein kinase 11-interacting protein, transcript variant X2
serine/threonine-protein kinase 11-interacting protein isoform X1
serine/threonine-protein kinase 11-interacting protein isoform X2
MAM and LDL-receptor class A domain-containing protein 2-like, transcript variant X1
MAM and LDL-receptor class A domain-containing protein 2-like, transcript variant X2
MAM and LDL-receptor class A domain-containing protein 2-like isoform X1
MAM and LDL-receptor class A domain-containing protein 2-like isoform X2
uncharacterized LOC114879869, transcript variant X2
uncharacterized LOC114879869, transcript variant X3
uncharacterized LOC114879869, transcript variant X1
BTB/POZ domain-containing protein 7, transcript variant X2
BTB/POZ domain-containing protein 7, transcript variant X3
BTB/POZ domain-containing protein 7, transcript variant X1
BTB/POZ domain-containing protein 7 isoform X2
BTB/POZ domain-containing protein 7 isoform X1
uncharacterized LOC114880863, transcript variant X2
uncharacterized LOC114880863, transcript variant X3
uncharacterized LOC114880863, transcript variant X1
GTP-binding protein 2, transcript variant X2
GTP-binding protein 2, transcript variant X1
GTP-binding protein 2, transcript variant X3
leukocyte elastase inhibitor-like, transcript variant X1
leukocyte elastase inhibitor-like, transcript variant X2
leukocyte elastase inhibitor-like, transcript variant X4
leukocyte elastase inhibitor-like, transcript variant X3
serine protease inhibitor 28Dc-like isoform X1
leukocyte elastase inhibitor-like isoform X2
DEAD-box ATP-dependent RNA helicase 20-like, transcript variant X2
DEAD-box ATP-dependent RNA helicase 20-like, transcript variant X1
DEAD-box ATP-dependent RNA helicase 20-like, transcript variant X4
DEAD-box ATP-dependent RNA helicase 20-like, transcript variant X3
DEAD-box ATP-dependent RNA helicase 20-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6, transcript variant X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6, transcript variant X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 isoform X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 isoform X2
lisH domain-containing protein ARMC9-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
lisH domain-containing protein ARMC9-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lisH domain-containing protein ARMC9-like isoform X1
lisH domain-containing protein ARMC9-like isoform X2
probable ATP-dependent RNA helicase ddx17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8, transcript variant X1
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8, transcript variant X3
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8, transcript variant X2
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8, transcript variant X4
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X1
uncharacterized protein LOC114875167 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase HUWE1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
methylated-DNA--protein-cysteine methyltransferase, constitutive
putative phosphatidate phosphatase, transcript variant X5
putative phosphatidate phosphatase isoform X5
putative phosphatidate phosphatase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
putative phosphatidate phosphatase, transcript variant X1
putative phosphatidate phosphatase, transcript variant X4
putative phosphatidate phosphatase, transcript variant X3
putative phosphatidate phosphatase isoform X2
putative phosphatidate phosphatase isoform X1
putative phosphatidate phosphatase isoform X3
putative phosphatidate phosphatase isoform X4
forkhead box protein J1-B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
forkhead box protein J1-B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
forkhead box protein J1-B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 4, transcript variant X1
dual specificity mitogen-activated protein kinase kinase 4, transcript variant X2
dual specificity mitogen-activated protein kinase kinase 4
limbic system-associated membrane protein-like, transcript variant X2
limbic system-associated membrane protein-like, transcript variant X3
limbic system-associated membrane protein-like, transcript variant X1
limbic system-associated membrane protein-like, transcript variant X8
limbic system-associated membrane protein-like, transcript variant X7
limbic system-associated membrane protein-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
limbic system-associated membrane protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
limbic system-associated membrane protein-like isoform X3
limbic system-associated membrane protein-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X2
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X4
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X1
ras-specific guanine nucleotide-releasing factor 2-like isoform X2
ras-specific guanine nucleotide-releasing factor 2-like isoform X3
ras-specific guanine nucleotide-releasing factor 2-like isoform X1
uncharacterized LOC114880372, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC114880372, transcript variant X2
uncharacterized LOC114880372, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nucleolar protein 4-like, transcript variant X4
nucleolar protein 4-like, transcript variant X5
nucleolar protein 4-like, transcript variant X3
nucleolar protein 4-like, transcript variant X1
nucleolar protein 4-like, transcript variant X2
WD repeat-containing and planar cell polarity effector protein fritz
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: WD repeat-containing and planar cell polarity effector protein fritz
uncharacterized LOC114877205, transcript variant X1
uncharacterized protein LOC114877205 isoform X1
uncharacterized LOC114877205, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC114877205 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X4
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X6
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X7
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X8
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X12
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X5
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X13
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X3
probable nuclear hormone receptor HR38 isoform X1
mediator of RNA polymerase II transcription subunit 12-like isoform X5
mediator of RNA polymerase II transcription subunit 12-like isoform X6
RNA polymerase II degradation factor 1-like isoform X8
probable nuclear hormone receptor HR38 isoform X2
probable nuclear hormone receptor HR38 isoform X3
RNA polymerase II degradation factor 1-like isoform X9
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X11
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X10
mediator of RNA polymerase II transcription subunit 12-like, transcript variant X9
homeotic protein female sterile-like isoform X7
zinc finger CCCH domain-containing protein 28-like
circadian locomoter output cycles protein kaput-like, transcript variant X1
circadian locomoter output cycles protein kaput-like, transcript variant X2
circadian locomoter output cycles protein kaput-like, transcript variant X4
circadian locomoter output cycles protein kaput-like, transcript variant X3
circadian locomoter output cycles protein kaput-like isoform X1
circadian locomoter output cycles protein kaput-like isoform X2
circadian locomoter output cycles protein kaput-like, transcript variant X5
circadian locomoter output cycles protein kaput-like isoform X3
mitochondrial basic amino acids transporter-like, transcript variant X1
mitochondrial basic amino acids transporter-like, transcript variant X2
mitochondrial basic amino acids transporter-like isoform X1
mitochondrial basic amino acids transporter-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
zinc transporter 1, transcript variant X4
zinc transporter 1, transcript variant X1
zinc transporter 1, transcript variant X6
zinc transporter 1, transcript variant X2
zinc transporter 1, transcript variant X7
zinc transporter 1, transcript variant X3
zinc transporter 1, transcript variant X5
uncharacterized LOC114880996, transcript variant X2
vascular endothelial growth factor receptor 1, transcript variant X1
vascular endothelial growth factor receptor 1, transcript variant X2
vascular endothelial growth factor receptor 1 isoform X1
vascular endothelial growth factor receptor 1 isoform X2
uncharacterized LOC114880996, transcript variant X3
uncharacterized LOC114880996, transcript variant X6
uncharacterized LOC114880996, transcript variant X4
uncharacterized LOC114880996, transcript variant X5
uncharacterized LOC114880996, transcript variant X1
uncharacterized protein LOC114880996 isoform X2
uncharacterized protein LOC114880996 isoform X1
uncharacterized protein LOC114880996 isoform X3
homocysteine S-methyltransferase 1-like, transcript variant X2
homocysteine S-methyltransferase 1-like, transcript variant X1
homocysteine S-methyltransferase 1-like isoform X1
homocysteine S-methyltransferase 2-like isoform X2
mitotic spindle assembly checkpoint protein MAD1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
lipase member H-like, transcript variant X1
lipase member H-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dedicator of cytokinesis protein 7, transcript variant X2
dedicator of cytokinesis protein 7, transcript variant X1
dedicator of cytokinesis protein 7 isoform X1
dedicator of cytokinesis protein 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein unc-13 homolog 4B, transcript variant X1
protein unc-13 homolog 4B, transcript variant X2
protein unc-13 homolog 4B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC114876883, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC114876883 isoform X1
uncharacterized LOC114876883, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC114876883 isoform X2
protein unc-13 homolog 4B, transcript variant X3
protein unc-13 homolog 4B, transcript variant X5
protein unc-13 homolog 4B, transcript variant X6
protein unc-13 homolog 4B, transcript variant X7
protein unc-13 homolog 4B, transcript variant X10
protein unc-13 homolog 4B, transcript variant X8
protein unc-13 homolog 4B, transcript variant X11
protein unc-13 homolog 4B, transcript variant X12
protein unc-13 homolog 4B, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC114876878, transcript variant X2
uncharacterized LOC114876878, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC114876875, transcript variant X1
uncharacterized LOC114876875, transcript variant X2
uncharacterized LOC114876875, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC114876875 isoform X1
uncharacterized protein LOC114876875 isoform X2
28S ribosomal protein S27, mitochondrial
coiled-coil domain-containing protein 22 homolog, transcript variant X2
coiled-coil domain-containing protein 22 homolog, transcript variant X1
coiled-coil domain-containing protein 22 homolog, transcript variant X3
coiled-coil domain-containing protein 22 homolog isoform X1
coiled-coil domain-containing protein 22 homolog isoform X2
coiled-coil domain-containing protein 22 homolog isoform X3
DENN domain-containing protein 5B, transcript variant X3
DENN domain-containing protein 5B, transcript variant X1
DENN domain-containing protein 5B, transcript variant X4
DENN domain-containing protein 5B, transcript variant X2
DENN domain-containing protein 5B isoform X3
DENN domain-containing protein 5A isoform X1
DENN domain-containing protein 5B isoform X4
DENN domain-containing protein 5A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114877949, transcript variant X2
uncharacterized LOC114877949, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
acidic phospholipase A2 PA4, transcript variant X1
acidic phospholipase A2 PA4, transcript variant X4
acidic phospholipase A2 PA4, transcript variant X3
acidic phospholipase A2 PA4, transcript variant X2
cyclic AMP response element-binding protein A, transcript variant X1
cyclic AMP response element-binding protein A, transcript variant X2
cyclic AMP response element-binding protein A
uncharacterized LOC114877970, transcript variant X2
uncharacterized LOC114877970, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC114877970, transcript variant X3
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X1
neutral ceramidase, transcript variant X4
serine protease nudel, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
serine protease nudel, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
neutral ceramidase, transcript variant X2
neutral ceramidase, transcript variant X5
neutral ceramidase, transcript variant X1
neutral ceramidase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC114877962, transcript variant X2
uncharacterized LOC114877962, transcript variant X3
uncharacterized LOC114877962, transcript variant X1
uncharacterized protein LOC114877962 isoform X2
uncharacterized protein LOC114877962 isoform X1
UHRF1-binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
UHRF1-binding protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
UHRF1-binding protein 1, transcript variant X3
UHRF1-binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
UHRF1-binding protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger CCCH domain-containing protein 11A-like
paired box protein Pax-6-like, transcript variant X2
paired box protein Pax-6-like, transcript variant X1
paired box protein Pax-6-like, transcript variant X3
paired box protein Pax-6-like isoform X2
paired box protein Pax-6-like isoform X1
post-GPI attachment to proteins factor 2-like, transcript variant X1
post-GPI attachment to proteins factor 2-like, transcript variant X4
post-GPI attachment to proteins factor 2-like, transcript variant X7
post-GPI attachment to proteins factor 2-like, transcript variant X2
post-GPI attachment to proteins factor 2-like, transcript variant X3
post-GPI attachment to proteins factor 2-like, transcript variant X6
post-GPI attachment to proteins factor 2-like, transcript variant X5
post-GPI attachment to proteins factor 2-like
integrator complex subunit 12-like, transcript variant X5
integrator complex subunit 12-like, transcript variant X4
integrator complex subunit 12-like, transcript variant X2
integrator complex subunit 12-like, transcript variant X1
integrator complex subunit 12-like, transcript variant X3
integrator complex subunit 12-like isoform X1
integrator complex subunit 12-like isoform X2
integrator complex subunit 12-like isoform X3
transcriptional enhancer factor TEF-1, transcript variant X5
transcriptional enhancer factor TEF-1, transcript variant X6
transcriptional enhancer factor TEF-1, transcript variant X4
transcriptional enhancer factor TEF-1, transcript variant X7
transcriptional enhancer factor TEF-1 isoform X5
transcriptional enhancer factor TEF-1 isoform X4
transcriptional enhancer factor TEF-1, transcript variant X3
transcriptional enhancer factor TEF-1 isoform X3
transcriptional enhancer factor TEF-1, transcript variant X1
transcriptional enhancer factor TEF-1, transcript variant X2
transcriptional enhancer factor TEF-1 isoform X1
optomotor-blind protein, transcript variant X3
optomotor-blind protein, transcript variant X1
optomotor-blind protein, transcript variant X2
coiled-coil domain-containing protein 86
putative leucine-rich repeat-containing protein DDB_G0290503
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC114878085, transcript variant X5
uncharacterized LOC114878085, transcript variant X2
uncharacterized LOC114878085, transcript variant X1
uncharacterized LOC114878085, transcript variant X4
uncharacterized LOC114878085, transcript variant X3
leucine-rich melanocyte differentiation-associated protein-like, transcript variant X2
leucine-rich melanocyte differentiation-associated protein-like, transcript variant X1
leucine-rich melanocyte differentiation-associated protein-like isoform X1
leucine-rich melanocyte differentiation-associated protein-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
synaptic vesicle glycoprotein 2C-like, transcript variant X2
synaptic vesicle glycoprotein 2C-like isoform X2
synaptic vesicle glycoprotein 2C-like, transcript variant X1
synaptic vesicle glycoprotein 2C-like isoform X1
synaptic vesicle glycoprotein 2C-like, transcript variant X3
synaptic vesicle glycoprotein 2C-like isoform X3
LOW QUALITY PROTEIN: insulin gene enhancer protein ISL-1
S phase cyclin A-associated protein in the endoplasmic reticulum
uncharacterized LOC114881982, transcript variant X2
uncharacterized LOC114881982, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
microtubule-associated protein futsch-like
m7GpppN-mRNA hydrolase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
m7GpppN-mRNA hydrolase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cytoplasmic polyadenylation element-binding protein 2
oligodendrocyte transcription factor 2-like
LIM domain-binding protein 2, transcript variant X6
LIM domain-binding protein 2, transcript variant X4
LIM domain-binding protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X3
LIM domain-binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phenoloxidase-activating factor 2-like, transcript variant X1
phenoloxidase-activating factor 2-like, transcript variant X3
phenoloxidase-activating factor 2-like, transcript variant X2
phenoloxidase-activating factor 2-like isoform X1
phenoloxidase-activating factor 2-like isoform X2
reticulocyte-binding protein homolog 1-like, transcript variant X3
reticulocyte-binding protein homolog 1-like, transcript variant X1
reticulocyte-binding protein homolog 1-like, transcript variant X2
reticulocyte-binding protein homolog 1-like isoform X1
reticulocyte-binding protein homolog 1-like isoform X2
reticulocyte-binding protein homolog 1-like isoform X3
transmembrane protein 230, transcript variant X1
transmembrane protein 230, transcript variant X6
transmembrane protein 230, transcript variant X5
transmembrane protein 230, transcript variant X4
transmembrane protein 230, transcript variant X2
transmembrane protein 230, transcript variant X3
uncharacterized LOC114873751, transcript variant X1
uncharacterized LOC114873751, transcript variant X4
uncharacterized LOC114873751, transcript variant X2
uncharacterized LOC114873751, transcript variant X3
uncharacterized LOC114873750, transcript variant X2
uncharacterized protein LOC114873750 isoform X2
uncharacterized LOC114873750, transcript variant X1
uncharacterized protein LOC114873750 isoform X1
receptor expression-enhancing protein 4-like, transcript variant X2
receptor expression-enhancing protein 4-like, transcript variant X4
receptor expression-enhancing protein 4-like, transcript variant X3
receptor expression-enhancing protein 4-like, transcript variant X1
receptor expression-enhancing protein 4-like, transcript variant X5
receptor expression-enhancing protein 3-B-like isoform X4
receptor expression-enhancing protein 4-like isoform X3
uncharacterized protein LOC114873697 isoform X2
uncharacterized protein LOC114873697 isoform X1
serine/arginine repetitive matrix protein 2, transcript variant X4
serine/arginine repetitive matrix protein 2, transcript variant X1
serine/arginine repetitive matrix protein 2, transcript variant X3
serine/arginine repetitive matrix protein 2, transcript variant X2
serine/arginine repetitive matrix protein 2, transcript variant X5
serine/arginine repetitive matrix protein 2 isoform X1
serine/arginine repetitive matrix protein 2 isoform X4
serine/arginine repetitive matrix protein 2 isoform X3
serine/arginine repetitive matrix protein 2 isoform X5
serine/arginine repetitive matrix protein 2 isoform X2
tyrosine-protein phosphatase non-receptor type 9, transcript variant X1
tyrosine-protein phosphatase non-receptor type 9, transcript variant X2
tyrosine-protein phosphatase non-receptor type 9 isoform X1
tyrosine-protein phosphatase non-receptor type 9 isoform X2
uncharacterized LOC114873726, transcript variant X3
uncharacterized LOC114873726, transcript variant X2
uncharacterized LOC114873726, transcript variant X1
uncharacterized protein LOC114873726 isoform X1
uncharacterized protein LOC114873726 isoform X2
RNA-binding protein 48, transcript variant X3
RNA-binding protein 48, transcript variant X1
RNA-binding protein 48, transcript variant X2
RNA-binding protein 48, transcript variant X4
protein kinase C-binding protein NELL1-like, transcript variant X2
protein kinase C-binding protein NELL1-like, transcript variant X1
protein kinase C-binding protein NELL1-like, transcript variant X4
protein kinase C-binding protein NELL1-like, transcript variant X3
protein kinase C-binding protein NELL1-like, transcript variant X5
protein kinase C-binding protein NELL1-like isoform X4
protein kinase C-binding protein NELL1-like isoform X1
protein kinase C-binding protein NELL1-like isoform X5
protein kinase C-binding protein NELL1-like isoform X3
protein kinase C-binding protein NELL1-like isoform X2
type IV secretion system protein virB10-like, transcript variant X1
type IV secretion system protein virB10-like, transcript variant X2
type IV secretion system protein virB10-like isoform X1
type IV secretion system protein virB10-like isoform X2
uncharacterized LOC114873756, transcript variant X1
uncharacterized LOC114873756, transcript variant X2
uncharacterized LOC114873756, transcript variant X3
uncharacterized protein LOC114873756 isoform X1
uncharacterized protein LOC114873756 isoform X2
leucine-rich repeat-containing protein 24-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
carbonic anhydrase-related protein 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
carbonic anhydrase-related protein 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
carbonic anhydrase-related protein 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC114873717 isoform X2
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase
ubiquitin carboxyl-terminal hydrolase 8-like, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 8-like, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 8-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 8-like, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 8-like isoform X1
ubiquitin carboxyl-terminal hydrolase 8-like isoform X2
mitochondrial amidoxime-reducing component 1-like, transcript variant X2
mitochondrial amidoxime-reducing component 1-like, transcript variant X1
mitochondrial amidoxime-reducing component 1-like isoform X2
mitochondrial amidoxime-reducing component 1-like isoform X1
mitogen-activated protein kinase kinase kinase 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein 431-like, transcript variant X1
zinc finger protein 431-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC114873735, transcript variant X1
uncharacterized LOC114873735, transcript variant X2
uncharacterized protein LOC114873735 isoform X1
uncharacterized protein LOC114873735 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
condensin-2 complex subunit G2-like, transcript variant X2
condensin-2 complex subunit G2-like, transcript variant X1
condensin-2 complex subunit G2-like isoform X1
condensin-2 complex subunit G2-like isoform X2
conserved oligomeric Golgi complex subunit 7, transcript variant X2
conserved oligomeric Golgi complex subunit 7, transcript variant X1
conserved oligomeric Golgi complex subunit 7
uncharacterized LOC114873733, transcript variant X1
uncharacterized LOC114873733, transcript variant X5
uncharacterized LOC114873733, transcript variant X6
uncharacterized LOC114873733, transcript variant X2
uncharacterized LOC114873733, transcript variant X3
uncharacterized LOC114873733, transcript variant X4
uncharacterized LOC114873742, transcript variant X2
uncharacterized protein LOC114873742 isoform X2
uncharacterized LOC114873742, transcript variant X3
uncharacterized LOC114873742, transcript variant X1
uncharacterized protein LOC114873742 isoform X1
GAS2-like protein pickled eggs, transcript variant X2
GAS2-like protein pickled eggs, transcript variant X1
GAS2-like protein pickled eggs isoform X2
GAS2-like protein pickled eggs isoform X1
RNA polymerase II subunit A C-terminal domain phosphatase SSU72
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
nuclear envelope integral membrane protein 1
probable sodium/potassium/calcium exchanger CG1090, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
probable sodium/potassium/calcium exchanger CG1090, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable sodium/potassium/calcium exchanger CG1090, transcript variant X4
probable sodium/potassium/calcium exchanger CG1090, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable sodium/potassium/calcium exchanger CG1090, transcript variant X5
probable sodium/potassium/calcium exchanger CG1090 isoform X1
probable sodium/potassium/calcium exchanger CG1090 isoform X2
apoptosis-inducing factor 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
apoptosis-inducing factor 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
apoptosis-inducing factor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
apoptosis-inducing factor 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
apoptosis-inducing factor 3, transcript variant X1
GATOR complex protein WDR24, transcript variant X1
GATOR complex protein WDR24, transcript variant X2
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X5
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X3
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X1
gamma-aminobutyric acid type B receptor subunit 2 isoform X2
gamma-aminobutyric acid type B receptor subunit 2 isoform X1
glucose dehydrogenase [FAD, quinone]-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
rh5-interacting protein-like, transcript variant X3
rh5-interacting protein-like, transcript variant X2
rh5-interacting protein-like, transcript variant X1
prion-like-(Q/N-rich) domain-bearing protein 25
prion-like-(Q/N-rich) domain-bearing protein 25, transcript variant X2
prion-like-(Q/N-rich) domain-bearing protein 25, transcript variant X1
39S ribosomal protein L51, mitochondrial, transcript variant X2
39S ribosomal protein L51, mitochondrial, transcript variant X1
39S ribosomal protein L51, mitochondrial
RNA-binding protein Musashi homolog 2, transcript variant X6
RNA-binding protein Musashi homolog 2, transcript variant X5
RNA-binding protein Musashi homolog 2, transcript variant X1
RNA-binding protein Musashi homolog 2, transcript variant X3
RNA-binding protein Musashi homolog 2, transcript variant X2
RNA-binding protein Musashi homolog 2, transcript variant X4
RNA-binding protein Musashi homolog 2, transcript variant X7
RNA-binding protein Musashi homolog 2 isoform X1
RNA-binding protein Musashi homolog 2 isoform X2
RNA-binding protein Musashi homolog 2 isoform X3
retinol dehydrogenase 14, transcript variant X1
retinol dehydrogenase 14, transcript variant X2
retinol dehydrogenase 14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
beta-1,4-galactosyltransferase 7, transcript variant X1
beta-1,4-galactosyltransferase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114875317, transcript variant X1
uncharacterized LOC114875317, transcript variant X2
uncharacterized protein LOC114875317 isoform X1
uncharacterized protein LOC114875317 isoform X2
myogenesis-regulating glycosidase, transcript variant X1
myogenesis-regulating glycosidase, transcript variant X2
myogenesis-regulating glycosidase, transcript variant X3
myogenesis-regulating glycosidase, transcript variant X4
myogenesis-regulating glycosidase, transcript variant X5
uncharacterized protein LOC114875316 isoform X1
myogenesis-regulating glycosidase isoform X2
myogenesis-regulating glycosidase isoform X3
myogenesis-regulating glycosidase isoform X4
nucleoside diphosphate kinase homolog 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
monocyte to macrophage differentiation factor 2
WD repeat domain phosphoinositide-interacting protein 2, transcript variant X2
WD repeat domain phosphoinositide-interacting protein 2, transcript variant X1
WD repeat domain phosphoinositide-interacting protein 2, transcript variant X3
WD repeat domain phosphoinositide-interacting protein 2 isoform X1
WD repeat domain phosphoinositide-interacting protein 2 isoform X3
WD repeat domain phosphoinositide-interacting protein 2 isoform X2
transitional endoplasmic reticulum ATPase TER94, transcript variant X2
transitional endoplasmic reticulum ATPase TER94, transcript variant X1
transitional endoplasmic reticulum ATPase TER94 isoform X2
transitional endoplasmic reticulum ATPase TER94 isoform X1
leptin receptor gene-related protein, transcript variant X2
leptin receptor gene-related protein, transcript variant X1
leptin receptor gene-related protein isoform X1
leptin receptor gene-related protein isoform X2
dynein axonemal heavy chain 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dynein axonemal heavy chain 3-like isoform X1
dynein axonemal heavy chain 3-like, transcript variant X2
dynein axonemal heavy chain 3-like isoform X2
dynein axonemal heavy chain 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dynein axonemal heavy chain 3-like isoform X3
probable small nuclear ribonucleoprotein Sm D1
probable malonyl-CoA-acyl carrier protein transacylase, mitochondrial, transcript variant X3
probable malonyl-CoA-acyl carrier protein transacylase, mitochondrial, transcript variant X2
probable malonyl-CoA-acyl carrier protein transacylase, mitochondrial, transcript variant X1
probable malonyl-CoA-acyl carrier protein transacylase, mitochondrial
uncharacterized LOC114875250, transcript variant X1
uncharacterized LOC114875250, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 isoform X1
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 isoform X2
vacuolar protein sorting-associated protein 54, transcript variant X1
vacuolar protein sorting-associated protein 54, transcript variant X3
vacuolar protein sorting-associated protein 54, transcript variant X2
vacuolar protein sorting-associated protein 54
cytoplasmic dynein 2 light intermediate chain 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
blood vessel epicardial substance-like, transcript variant X8
blood vessel epicardial substance-like, transcript variant X7
blood vessel epicardial substance-like, transcript variant X2
blood vessel epicardial substance-like, transcript variant X3
blood vessel epicardial substance-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
blood vessel epicardial substance-like, transcript variant X1
blood vessel epicardial substance-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
blood vessel epicardial substance-like, transcript variant X5
blood vessel epicardial substance-like isoform X2
blood vessel epicardial substance-like isoform X1
E3 ubiquitin-protein ligase RBBP6, transcript variant X1
E3 ubiquitin-protein ligase RBBP6, transcript variant X2
activating signal cointegrator 1 complex subunit 3, transcript variant X3
activating signal cointegrator 1 complex subunit 3, transcript variant X2
activating signal cointegrator 1 complex subunit 3, transcript variant X1
activating signal cointegrator 1 complex subunit 3, transcript variant X4
activating signal cointegrator 1 complex subunit 3
DCN1-like protein 3, transcript variant X2
DCN1-like protein 3, transcript variant X1
CCR4-NOT transcription complex subunit 2-like, transcript variant X1
CCR4-NOT transcription complex subunit 2-like, transcript variant X5
CCR4-NOT transcription complex subunit 2-like, transcript variant X3
CCR4-NOT transcription complex subunit 2-like, transcript variant X4
CCR4-NOT transcription complex subunit 2-like, transcript variant X2
CCR4-NOT transcription complex subunit 2-like isoform X1
CCR4-NOT transcription complex subunit 2-like isoform X2
malonyl-CoA decarboxylase, mitochondrial-like
uncharacterized LOC123988045, transcript variant X3
uncharacterized LOC123988045, transcript variant X4
uncharacterized LOC123988045, transcript variant X1
uncharacterized LOC123988045, transcript variant X2
uncharacterized protein LOC123988045 isoform X1
uncharacterized protein LOC123988045 isoform X2
regulatory-associated protein of mTOR, transcript variant X1
regulatory-associated protein of mTOR, transcript variant X2
regulatory-associated protein of mTOR isoform X1
regulatory-associated protein of mTOR isoform X2
clathrin heavy chain, transcript variant X2
clathrin heavy chain, transcript variant X1
60S acidic ribosomal protein P2, transcript variant X1
60S acidic ribosomal protein P2, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00535
beta-1,4-mannosyltransferase egh, transcript variant X2
beta-1,4-mannosyltransferase egh, transcript variant X1
WD repeat-containing protein 81, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
WD repeat-containing protein 81, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
WD repeat-containing protein 81, transcript variant X7
WD repeat-containing protein 81, transcript variant X4
WD repeat-containing protein 81, transcript variant X5
WD repeat-containing protein 81, transcript variant X6
WD repeat-containing protein 81, transcript variant X1
WD repeat-containing protein 81 isoform X1
WD repeat-containing protein 81 isoform X5
WD repeat-containing protein 81 isoform X2
WD repeat-containing protein 81 isoform X3
WD repeat-containing protein 81 isoform X4
RAD50-interacting protein 1, transcript variant X1
RAD50-interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
RAD50-interacting protein 1, transcript variant X3
uncharacterized LOC114875178, transcript variant X3
uncharacterized LOC114875178, transcript variant X2
uncharacterized LOC114875178, transcript variant X1
uncharacterized LOC114875175, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC114875175, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC114875175 isoform X1
uncharacterized protein LOC114875175 isoform X2
vacuolar protein sorting-associated protein 52 homolog
X-ray repair cross-complementing protein 6
antichymotrypsin-2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
antichymotrypsin-2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
antichymotrypsin-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
antichymotrypsin-2-like, transcript variant X2
antichymotrypsin-2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
antichymotrypsin-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
antichymotrypsin-2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
antichymotrypsin-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC114875243, transcript variant X4
uncharacterized LOC114875243, transcript variant X3
uncharacterized LOC114875243, transcript variant X1
uncharacterized LOC114875243, transcript variant X2
methylglutaconyl-CoA hydratase, mitochondrial, transcript variant X1
methylglutaconyl-CoA hydratase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
methylglutaconyl-CoA hydratase, mitochondrial
phosphomannomutase, transcript variant X4
phosphomannomutase, transcript variant X1
phosphomannomutase, transcript variant X3
phosphomannomutase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC114875242, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC114875242, transcript variant X1
uncharacterized LOC114875240, transcript variant X1
uncharacterized LOC114875240, transcript variant X2
uncharacterized LOC114875240, transcript variant X3
uncharacterized protein LOC114875240 isoform X2
uncharacterized protein LOC114875240 isoform X1
mediator of RNA polymerase II transcription subunit 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 124 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
cuticle protein 21-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 146 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cuticle protein 21-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 148 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 110 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
structural maintenance of chromosomes protein 6, transcript variant X3
structural maintenance of chromosomes protein 6, transcript variant X1
structural maintenance of chromosomes protein 6, transcript variant X2
structural maintenance of chromosomes protein 6
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 5 codons; deleted 5 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 5 codons; deleted 5 bases in 4 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC114875225
antichymotrypsin-2-like, transcript variant X9
serine protease inhibitor 3/4-like isoform X7
serine protease inhibitor 3/4-like isoform X8
serine protease inhibitor 3/4-like isoform X4
serine protease inhibitor 3/4-like isoform X2
antichymotrypsin-2-like, transcript variant X12
antichymotrypsin-2-like, transcript variant X13
serine protease inhibitor 3/4-like isoform X5
serine protease inhibitor 3/4-like isoform X6
antichymotrypsin-2-like, transcript variant X14
serine protease inhibitor 3/4-like isoform X3
serine protease inhibitor 3/4-like isoform X13
antichymotrypsin-2-like, transcript variant X10
serine protease inhibitor 3/4-like isoform X9
antichymotrypsin-2-like, transcript variant X11
serine protease inhibitor 3/4-like isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
EKC/KEOPS complex subunit TPRKB-like, transcript variant X1
EKC/KEOPS complex subunit TPRKB-like, transcript variant X2
EKC/KEOPS complex subunit Tprkb-like isoform X2
EKC/KEOPS complex subunit TPRKB-like isoform X1
nuclear protein localization protein 4 homolog, transcript variant X1
nuclear protein localization protein 4 homolog, transcript variant X3
nuclear protein localization protein 4 homolog, transcript variant X2
nuclear protein localization protein 4 homolog, transcript variant X4
nuclear protein localization protein 4 homolog isoform X2
nuclear protein localization protein 4 homolog isoform X1
uncharacterized LOC114875227, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC114875227, transcript variant X1
uncharacterized LOC114875230, transcript variant X8
uncharacterized LOC114875230, transcript variant X5
uncharacterized LOC114875230, transcript variant X3
uncharacterized LOC114875230, transcript variant X1
uncharacterized LOC114875230, transcript variant X2
uncharacterized LOC114875230, transcript variant X10
uncharacterized LOC114875230, transcript variant X9
uncharacterized protein LOC114875230 isoform X1
uncharacterized protein LOC114875230 isoform X4
uncharacterized protein LOC114875230 isoform X2
uncharacterized protein LOC114875230 isoform X5
uncharacterized LOC114875230, transcript variant X4
uncharacterized LOC114875230, transcript variant X6
uncharacterized LOC114875230, transcript variant X7
uncharacterized protein LOC114875230 isoform X3
sodium-independent sulfate anion transporter-like
eukaryotic translation initiation factor 2 subunit 1
sister chromatid cohesion protein PDS5 homolog B, transcript variant X1
sister chromatid cohesion protein PDS5 homolog B, transcript variant X2
sister chromatid cohesion protein PDS5 homolog B-B isoform X1
sister chromatid cohesion protein PDS5 homolog B isoform X2
probable ATP-dependent RNA helicase DDX27
flap endonuclease 1, transcript variant X2
flap endonuclease 1, transcript variant X1
flap endonuclease 1, transcript variant X4
flap endonuclease 1, transcript variant X6
flap endonuclease 1, transcript variant X5
flap endonuclease 1, transcript variant X3
reticulon-4-interacting protein 1 homolog, mitochondrial-like, transcript variant X1
reticulon-4-interacting protein 1 homolog, mitochondrial-like, transcript variant X2
reticulon-4-interacting protein 1 homolog, mitochondrial-like
mitochondrial GTPase 1, transcript variant X2
phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1
mitochondrial GTPase 1, transcript variant X1
alanine--tRNA ligase, mitochondrial, transcript variant X3
alanine--tRNA ligase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
alanine--tRNA ligase, mitochondrial, transcript variant X2
RNA-binding protein 4.1-like, transcript variant X6
RNA-binding protein 4.1-like, transcript variant X2
RNA-binding protein 4.1-like, transcript variant X5
RNA-binding protein 4.1-like, transcript variant X1
RNA-binding protein 4.1-like, transcript variant X8
RNA-binding protein 4.1-like, transcript variant X3
RNA-binding protein 4.1-like, transcript variant X7
RNA-binding protein 4.1-like, transcript variant X4
phosphoacetylglucosamine mutase, transcript variant X3
phosphoacetylglucosamine mutase, transcript variant X2
phosphoacetylglucosamine mutase isoform X2
phosphoacetylglucosamine mutase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA (cytosine-5)-methyltransferase 1 isoform X1
uncharacterized LOC114875272, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC114875272, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC114875272, transcript variant X1
uncharacterized protein LOC114875272 isoform X2
uncharacterized protein LOC114875272 isoform X1
uncharacterized protein LOC114875272 isoform X3
phospholipid phosphatase 1-like, transcript variant X1
phospholipid phosphatase 1-like isoform X1
phospholipid phosphatase 1-like, transcript variant X3
phospholipid phosphatase 1-like isoform X3
phospholipid phosphatase 1-like, transcript variant X2
phospholipid phosphatase 1-like isoform X2
uncharacterized LOC114875278, transcript variant X3
uncharacterized LOC114875278, transcript variant X2
uncharacterized LOC114875278, transcript variant X1
ras-related protein Rab-35, transcript variant X2
ras-related protein Rab-35, transcript variant X1
tRNA selenocysteine 1-associated protein 1, transcript variant X1
tRNA selenocysteine 1-associated protein 1, transcript variant X2
tRNA selenocysteine 1-associated protein 1 isoform X1
tRNA selenocysteine 1-associated protein 1 isoform X2
transcription factor TFIIIB component B'' homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transcription factor TFIIIB component B'' homolog isoform X2
transcription factor TFIIIB component B'' homolog, transcript variant X1
transcription factor TFIIIB component B'' homolog isoform X1
WD and tetratricopeptide repeats protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
WD and tetratricopeptide repeats protein 1-like, transcript variant X3
WD and tetratricopeptide repeats protein 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
WD and tetratricopeptide repeats protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
WD and tetratricopeptide repeats protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
WD and tetratricopeptide repeats protein 1-like, transcript variant X5
WD and tetratricopeptide repeats protein 1-like
zinc finger Ran-binding domain-containing protein 2-like, transcript variant X1
zinc finger Ran-binding domain-containing protein 2-like, transcript variant X2
zinc finger Ran-binding domain-containing protein 2-like, transcript variant X3
zinc finger Ran-binding domain-containing protein 2-like, transcript variant X4
zinc finger Ran-binding domain-containing protein 2-like, transcript variant X5
zinc finger Ran-binding domain-containing protein 2-like, transcript variant X6
zinc finger Ran-binding domain-containing protein 2-like, transcript variant X7
zinc finger Ran-binding domain-containing protein 2-like, transcript variant X8
zinc finger Ran-binding domain-containing protein 2-like isoform X1
zinc finger Ran-binding domain-containing protein 2-like isoform X2
zinc finger Ran-binding domain-containing protein 2-like isoform X3
protein BCL9 homolog, transcript variant X4
protein BCL9 homolog, transcript variant X3
protein BCL9 homolog, transcript variant X2
protein BCL9 homolog, transcript variant X1
plasminogen activator inhibitor 1 RNA-binding protein-like
eukaryotic translation initiation factor 3 subunit H
calcium/calmodulin-dependent protein kinase type 1, transcript variant X1
calcium/calmodulin-dependent protein kinase type 1, transcript variant X2
calcium/calmodulin-dependent protein kinase type 1 isoform X2
calcium/calmodulin-dependent protein kinase type 1 isoform X1
calcium/calmodulin-dependent protein kinase type 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type 1, transcript variant X4
calcium/calmodulin-dependent protein kinase type 1 isoform X4
calcium/calmodulin-dependent protein kinase type 1 isoform X3
calcium/calmodulin-dependent protein kinase type 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type 1 isoform X5
non-structural maintenance of chromosomes element 1 homolog, transcript variant X3
non-structural maintenance of chromosomes element 1 homolog, transcript variant X4
non-structural maintenance of chromosomes element 1 homolog, transcript variant X1
non-structural maintenance of chromosomes element 1 homolog, transcript variant X2
non-structural maintenance of chromosomes element 1 homolog
coiled-coil domain-containing protein 174
translation initiation factor IF-2-like, transcript variant X3
translation initiation factor IF-2-like, transcript variant X2
translation initiation factor IF-2-like, transcript variant X1
translation initiation factor IF-2-like isoform X1
translation initiation factor IF-2-like isoform X2
transcription factor SPT20 homolog, transcript variant X4
transcription factor SPT20 homolog, transcript variant X5
putative uncharacterized protein DDB_G0271606 isoform X4
putative uncharacterized protein DDB_G0271606 isoform X5
transcription factor SPT20 homolog, transcript variant X3
transcription factor SPT20 homolog, transcript variant X1
transcription factor SPT20 homolog, transcript variant X2
putative uncharacterized protein DDB_G0271606 isoform X1
transcription factor SPT20 homolog isoform X3
putative uncharacterized protein DDB_G0271606 isoform X2
uncharacterized LOC114875282, transcript variant X4
uncharacterized LOC114875282, transcript variant X3
uncharacterized LOC114875282, transcript variant X7
uncharacterized LOC114875282, transcript variant X1
uncharacterized LOC114875282, transcript variant X2
uncharacterized LOC114875282, transcript variant X5
uncharacterized LOC114875282, transcript variant X6
uncharacterized protein LOC114875282 isoform X1
uncharacterized protein LOC114875282 isoform X2
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, transcript variant X1
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, transcript variant X2
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, transcript variant X3
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial isoform X1
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial isoform X2
mitogen-activated protein kinase p38b-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
mitogen-activated protein kinase p38b-like, transcript variant X2
mitogen-activated protein kinase p38b-like, transcript variant X1
mitogen-activated protein kinase p38b-like isoform X1
mitogen-activated protein kinase p38b-like isoform X2
mitogen-activated protein kinase p38b-like isoform X3
uncharacterized LOC114879914, transcript variant X1
uncharacterized LOC114879914, transcript variant X3
uncharacterized LOC114879914, transcript variant X2
uncharacterized protein LOC114879914 isoform X1
uncharacterized protein LOC114879914 isoform X2
uncharacterized protein LOC114879914 isoform X3
trimeric intracellular cation channel type 1B.1, transcript variant X1
trimeric intracellular cation channel type 1B.1, transcript variant X2
trimeric intracellular cation channel type 1B.1 isoform X1
trimeric intracellular cation channel type 1B.1 isoform X2
endoplasmic reticulum metallopeptidase 1-like
uncharacterized LOC114879923, transcript variant X5
uncharacterized protein LOC114879923 isoform X2
uncharacterized LOC114879923, transcript variant X1
uncharacterized LOC114879923, transcript variant X2
uncharacterized LOC114879923, transcript variant X4
uncharacterized LOC114879923, transcript variant X3
uncharacterized protein LOC114879923 isoform X1
cysteine and histidine-rich protein 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
39S ribosomal protein L23, mitochondrial, transcript variant X2
39S ribosomal protein L23, mitochondrial, transcript variant X1
39S ribosomal protein L23, mitochondrial
potassium channel subfamily K member 18-like, transcript variant X2
potassium channel subfamily K member 18-like, transcript variant X1
potassium channel subfamily K member 18-like isoform X2
potassium channel subfamily K member 18-like isoform X1
potassium channel subfamily K member 18, transcript variant X1
potassium channel subfamily K member 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC114879927, transcript variant X1
uncharacterized LOC114879927, transcript variant X3
uncharacterized LOC114879927, transcript variant X2
uncharacterized LOC114879927, transcript variant X4
uncharacterized LOC114879940, transcript variant X1
uncharacterized LOC114879940, transcript variant X2
coiled-coil domain-containing protein 112-like
nipped-B-like protein, transcript variant X2
nipped-B-like protein, transcript variant X1
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X3
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X4
aryl hydrocarbon receptor nuclear translocator homolog isoform X3
aryl hydrocarbon receptor nuclear translocator homolog isoform X4
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X6
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X7
aryl hydrocarbon receptor nuclear translocator homolog isoform X6
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X1
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X2
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X5
aryl hydrocarbon receptor nuclear translocator homolog isoform X1
aryl hydrocarbon receptor nuclear translocator homolog isoform X2
aryl hydrocarbon receptor nuclear translocator homolog isoform X5
U3 small nucleolar ribonucleoprotein protein MPP10
spectrin beta chain, non-erythrocytic 5, transcript variant X4
spectrin beta chain, non-erythrocytic 5, transcript variant X1
spectrin beta chain, non-erythrocytic 5, transcript variant X2
spectrin beta chain, non-erythrocytic 5, transcript variant X3
spectrin beta chain, non-erythrocytic 5 isoform X1
spectrin beta chain, non-erythrocytic 5 isoform X3
spectrin beta chain, non-erythrocytic 5 isoform X2
spectrin beta chain, non-erythrocytic 5 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
ER degradation-enhancing alpha-mannosidase-like protein 2
vesicular inhibitory amino acid transporter, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
vesicular inhibitory amino acid transporter, transcript variant X2
vesicular inhibitory amino acid transporter
ubiquitin carboxyl-terminal hydrolase 20
uncharacterized LOC114877640, transcript variant X8
uncharacterized protein LOC114877640 isoform X4
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X1
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X7
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X9
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X3
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X2
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X4
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X6
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X5
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X8
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X10
mitogen-activated protein kinase kinase kinase kinase 5 isoform X1
mitogen-activated protein kinase kinase kinase kinase 5 isoform X7
mitogen-activated protein kinase kinase kinase kinase 5 isoform X3
mitogen-activated protein kinase kinase kinase kinase 5 isoform X9
mitogen-activated protein kinase kinase kinase kinase 5 isoform X2
mitogen-activated protein kinase kinase kinase kinase 5 isoform X4
mitogen-activated protein kinase kinase kinase kinase 5 isoform X6
mitogen-activated protein kinase kinase kinase kinase 5 isoform X5
mitogen-activated protein kinase kinase kinase kinase 5 isoform X8
mitogen-activated protein kinase kinase kinase kinase 3 isoform X10
uncharacterized LOC114877640, transcript variant X4
uncharacterized LOC114877640, transcript variant X3
uncharacterized LOC114877640, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC114877640, transcript variant X1
uncharacterized LOC114877640, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC114877640, transcript variant X5
uncharacterized LOC114877640, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized protein LOC114877640 isoform X2
uncharacterized protein LOC114877640 isoform X1
uncharacterized protein LOC114877640 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
ras-related protein Rap1, transcript variant X2
ras-related protein Rap1, transcript variant X1
myotubularin-related protein 14, transcript variant X2
myotubularin-related protein 14, transcript variant X1
IQ motif and SEC7 domain-containing protein 2, transcript variant X1
IQ motif and SEC7 domain-containing protein 2, transcript variant X5
IQ motif and SEC7 domain-containing protein 2, transcript variant X7
IQ motif and SEC7 domain-containing protein 2, transcript variant X4
IQ motif and SEC7 domain-containing protein 2 isoform X1
IQ motif and SEC7 domain-containing protein 2 isoform X4
IQ motif and SEC7 domain-containing protein 2 isoform X6
IQ motif and SEC7 domain-containing protein 2 isoform X3
IQ motif and SEC7 domain-containing protein 2, transcript variant X6
IQ motif and SEC7 domain-containing protein 2 isoform X5
IQ motif and SEC7 domain-containing protein 2, transcript variant X2
IQ motif and SEC7 domain-containing protein 2, transcript variant X3
IQ motif and SEC7 domain-containing protein 1 isoform X2
IQ motif and SEC7 domain-containing protein 2, transcript variant X9
IQ motif and SEC7 domain-containing protein 2 isoform X8
IQ motif and SEC7 domain-containing protein 2, transcript variant X8
IQ motif and SEC7 domain-containing protein 2 isoform X7
carbohydrate sulfotransferase 11, transcript variant X2
carbohydrate sulfotransferase 11, transcript variant X1
carbohydrate sulfotransferase 11 isoform X1
carbohydrate sulfotransferase 11 isoform X2
myocyte-specific enhancer factor 2, transcript variant X1
myocyte-specific enhancer factor 2, transcript variant X7
myocyte-specific enhancer factor 2, transcript variant X6
myocyte-specific enhancer factor 2, transcript variant X3
myocyte-specific enhancer factor 2, transcript variant X4
myocyte-specific enhancer factor 2, transcript variant X5
myocyte-specific enhancer factor 2, transcript variant X2
myocyte-specific enhancer factor 2 isoform X3
myocyte-specific enhancer factor 2 isoform X2
myocyte-specific enhancer factor 2 isoform X1
protein mono-ADP-ribosyltransferase PARP16, transcript variant X4
protein mono-ADP-ribosyltransferase PARP16, transcript variant X1
protein mono-ADP-ribosyltransferase PARP16, transcript variant X2
protein mono-ADP-ribosyltransferase PARP16 isoform X1
protein mono-ADP-ribosyltransferase PARP16, transcript variant X3
protein mono-ADP-ribosyltransferase PARP16 isoform X2
vacuolar protein sorting-associated protein 26C
uncharacterized LOC114877634, transcript variant X1
uncharacterized protein LOC114877634 isoform X1
uncharacterized LOC114877634, transcript variant X2
uncharacterized protein LOC114877634 isoform X2
histone-lysine N-methyltransferase PR-Set7
protein strawberry notch, transcript variant X2
protein strawberry notch, transcript variant X1
Golgi SNAP receptor complex member 1, transcript variant X1
Golgi SNAP receptor complex member 1, transcript variant X2
Golgi SNAP receptor complex member 1 isoform X1
Golgi SNAP receptor complex member 1 isoform X2
oxysterol-binding protein 1, transcript variant X1
oxysterol-binding protein 1, transcript variant X4
oxysterol-binding protein 1, transcript variant X2
oxysterol-binding protein 1, transcript variant X5
oxysterol-binding protein 1, transcript variant X3
oxysterol-binding protein 1, transcript variant X12
oxysterol-binding protein 1, transcript variant X6
oxysterol-binding protein 1, transcript variant X9
oxysterol-binding protein 1, transcript variant X8
oxysterol-binding protein 1, transcript variant X11
oxysterol-binding protein 1, transcript variant X7
oxysterol-binding protein 1, transcript variant X10
14-3-3 protein epsilon, transcript variant X1
14-3-3 protein epsilon, transcript variant X2
general transcription factor IIH subunit 3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X3
venom dipeptidyl peptidase 4-like, transcript variant X2
venom dipeptidyl peptidase 4-like, transcript variant X3
venom dipeptidyl peptidase 4-like, transcript variant X4
venom dipeptidyl peptidase 4-like isoform X2
venom dipeptidyl peptidase 4-like, transcript variant X1
venom dipeptidyl peptidase 4-like isoform X1
DNA-directed RNA polymerase I subunit RPA12
molybdenum cofactor sulfurase 3, transcript variant X2
molybdenum cofactor sulfurase 3, transcript variant X1
molybdenum cofactor sulfurase 3, transcript variant X4
molybdenum cofactor sulfurase 3, transcript variant X3
molybdenum cofactor sulfurase 3 isoform X2
molybdenum cofactor sulfurase 3 isoform X1
molybdenum cofactor sulfurase 3 isoform X4
molybdenum cofactor sulfurase 3 isoform X3
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-zipper-like transcriptional regulator 1, transcript variant X2
leucine-zipper-like transcriptional regulator 1, transcript variant X1
leucine-zipper-like transcriptional regulator 1, transcript variant X3
leucine-zipper-like transcriptional regulator 1, transcript variant X4
leucine-zipper-like transcriptional regulator 1 isoform X1
leucine-zipper-like transcriptional regulator 1 isoform X2
leucine-zipper-like transcriptional regulator 1 isoform X3
pleckstrin homology domain-containing family G member 5-like, transcript variant X5
pleckstrin homology domain-containing family G member 5-like, transcript variant X3
pleckstrin homology domain-containing family G member 5-like, transcript variant X4
pleckstrin homology domain-containing family G member 5-like, transcript variant X2
pleckstrin homology domain-containing family G member 5-like, transcript variant X1
pleckstrin homology domain-containing family G member 5-like, transcript variant X10
pleckstrin homology domain-containing family G member 5-like, transcript variant X6
pleckstrin homology domain-containing family G member 5-like, transcript variant X9
pleckstrin homology domain-containing family G member 5-like, transcript variant X13
pleckstrin homology domain-containing family G member 5-like, transcript variant X11
pleckstrin homology domain-containing family G member 5-like, transcript variant X7
pleckstrin homology domain-containing family G member 5-like, transcript variant X15
pleckstrin homology domain-containing family G member 5-like, transcript variant X8
pleckstrin homology domain-containing family G member 5-like, transcript variant X14
pleckstrin homology domain-containing family G member 5-like isoform X8
pleckstrin homology domain-containing family G member 5-like isoform X3
pleckstrin homology domain-containing family G member 5-like isoform X6
pleckstrin homology domain-containing family G member 5-like isoform X10
pleckstrin homology domain-containing family G member 5-like isoform X4
pleckstrin homology domain-containing family G member 5-like isoform X5
pleckstrin homology domain-containing family G member 5-like isoform X2
pleckstrin homology domain-containing family G member 5-like isoform X1
pleckstrin homology domain-containing family G member 5-like isoform X9
pleckstrin homology domain-containing family G member 5-like, transcript variant X12
pleckstrin homology domain-containing family G member 5-like isoform X7
arginine/serine-rich protein PNISR-like, transcript variant X1
arginine/serine-rich protein PNISR-like, transcript variant X2
arginine/serine-rich protein PNISR-like isoform X1
arginine/serine-rich protein PNISR-like isoform X2
circadian locomoter output cycles protein kaput, transcript variant X2
circadian locomoter output cycles protein kaput, transcript variant X1
circadian locomoter output cycles protein kaput
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 2 codons; deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 2 codons; deleted 3 bases in 2 codons; substituted 5 bases at 5 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane protein 164
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
LOW QUALITY PROTEIN: F-box/SPRY domain-containing protein 1
ras-related protein Rab-27A, transcript variant X1
ras-related protein Rab-27A, transcript variant X2
uncharacterized LOC114876441, transcript variant X4
uncharacterized LOC114876441, transcript variant X5
uncharacterized LOC114876441, transcript variant X6
uncharacterized LOC114876441, transcript variant X10
uncharacterized LOC114876441, transcript variant X1
uncharacterized LOC114876441, transcript variant X3
uncharacterized LOC114876441, transcript variant X2
uncharacterized LOC114876441, transcript variant X9
uncharacterized protein LOC114876441 isoform X2
uncharacterized LOC114876441, transcript variant X7
protein artichoke-like, transcript variant X2
uncharacterized LOC114876441, transcript variant X8
protein artichoke-like, transcript variant X5
protein artichoke-like, transcript variant X1
protein artichoke-like, transcript variant X6
protein artichoke-like, transcript variant X4
uncharacterized protein LOC114876441 isoform X1
protein artichoke-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
signal peptidase complex catalytic subunit SEC11A
probable cytochrome P450 304a1, transcript variant X2
probable cytochrome P450 304a1, transcript variant X1
probable cytochrome P450 304a1 isoform X2
probable cytochrome P450 304a1 isoform X1
uncharacterized LOC114876439, transcript variant X1
uncharacterized LOC114876439, transcript variant X2
uncharacterized LOC114876439, transcript variant X4
uncharacterized LOC114876439, transcript variant X3
uncharacterized protein LOC114876439 isoform X1
uncharacterized protein LOC114876439 isoform X2
uncharacterized protein LOC114876439 isoform X4
uncharacterized protein LOC114876439 isoform X3
uncharacterized LOC114876439, transcript variant X5
disintegrin and metalloproteinase domain-containing protein 10-like, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 10-like, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 10-like isoform X1
disintegrin and metalloproteinase domain-containing protein 10-like isoform X2
60S ribosomal protein L29-1, transcript variant X2
60S ribosomal protein L29-1, transcript variant X1
calcium-independent phospholipase A2-gamma-like, transcript variant X2
calcium-independent phospholipase A2-gamma-like, transcript variant X1
calcium-independent phospholipase A2-gamma-like, transcript variant X4
calcium-independent phospholipase A2-gamma-like, transcript variant X3
calcium-independent phospholipase A2-gamma-like isoform X2
calcium-independent phospholipase A2-gamma-like isoform X1
calcium-independent phospholipase A2-gamma-like isoform X3
calcium-independent phospholipase A2-gamma-like isoform X4